Mission Board on Vaccination in Europe

𝗟𝗲𝘁’𝘀 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗹𝗮𝘀𝘁 𝗰𝗵𝗮𝗽𝘁𝗲𝗿 𝗼𝗻 𝗰𝗿𝗼𝘀𝘀-𝗰𝘂𝘁𝘁𝗶𝗻𝗴 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀! As we delve into the final chapter of our report, we spotlight critical cross-cutting themes that emerge from the report: 🔹 𝗟𝗶𝗳𝗲 𝗰𝗼𝘂𝗿𝘀𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 🔹 𝗜𝗻𝘁𝗲𝗿-𝘀𝗲𝗰𝘁𝗼𝗿𝗮𝗹 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻  🔹 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗼𝗳 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 🔹 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗻𝗴 Building on these pillars, the chapter outlines actionable recommendations: 🚨 𝗗𝗲𝘃𝗲𝗹𝗼𝗽 𝗮𝗻𝗱 𝗶𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗲𝘀 𝘁𝗼 𝘀𝘆𝘀𝘁𝗲𝗺𝗮𝘁𝗶𝗰𝗮𝗹𝗹𝘆 𝗺𝗼𝗻𝗶𝘁𝗼𝗿, 𝗮𝘀𝘀𝗲𝘀𝘀, 𝗮𝗻𝗱 𝗽𝘂𝗯𝗹𝗶𝗰𝗹𝘆 𝗿𝗲𝗽𝗼𝗿𝘁 𝗼𝗻 𝘁𝗵𝗲 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗼𝗳 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝘀𝘆𝘀𝘁𝗲𝗺𝘀.  ➡ Create a national framework to monitor and assess immunisation performance, setting clear goals and identifying indicators to measure progress. ➡ Engage a geographically balanced expert group to design model frameworks, identify best practices, and expand EU-level monitoring through standardised indicators.  📢 𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗻𝗴 𝗼𝗳 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝗮𝘀 𝗮𝗻 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗶𝗻 𝗶𝗻𝘁𝗲𝗿 𝗮𝗹𝗶𝗮 𝗽𝘂𝗯𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵, 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺 𝘀𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆, 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝗮𝗴𝗲𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗲𝗰𝗼𝗻𝗼𝗺𝗶𝗰 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲.  ➡ Protect prevention budgets from short-term cost-cutting measures. ➡ Monitor and promote prevention spending as a key investment in health, resilience, and economic performance through the EU’s European Semester process. Together, these cross-cutting recommendations pave the way for robust and future-ready immunisation systems. Let’s continue advancing these vital efforts! 🌍 👉 https://lnkd.in/ehVPf-px

Exploring Chapter 4 of our Consensus Report: Convergence and alignment! While decisions on vaccination schedules remain a national competence, disparities in these processes are unjustifiable on public health grounds. Such differences lead to unequal health protection for citizens, erode vaccine confidence, and underscore the urgent need for a more harmonised approach. MBVE’s recommended actions include: 📆Develop a more aligned approach to life course immunisation through a core calendar for adult vaccination. 💡Address key gaps in decision-making pathways on vaccination to enhance their consistency, inclusivity, transparency, and accountability. This need for action was also highlighted in the European Commission’s 2018 Communication on strengthened cooperation against vaccine-preventable diseases (VPDs). Furthermore, best practices in decision-making should be shared and amplified through the EU NITAG Network to drive alignment. 🤝It’s time to act! By fostering greater alignment and transparency, we can ensure equitable health protection, restore public trust, and build a healthier Europe! Stay tuned for final Chapter on cross-cutting themes! 👉 https://lnkd.in/ehVPf-px

Let’s dive into Chapter 3 of our Consensus Report: Citizens’ Access to Vaccines! Access to preventative health care is a fundamental right, as highlighted in the European Charter of Fundamental Rights. Yet, many barriers persist, limiting citizens’ ability to access vaccines: ➡Prolonged decision-making processes on National Immunisation Programmes (NIP): In 1/3 of European countries, it takes over 6 years for vaccines to become accessible to the population. ➡Barriers for disadvantaged population groups: Documentation requirements, limited healthcare accessibility, and linguistic or cultural obstacles continue to leave many behind to access vaccine. Our recommended actions to address these issues: ⏱️ Speed up evidence-based decision-making to ensure timely, equitable access to vaccines across all populations  🎒 Make vaccination services more accessible, especially in schools, workplaces, and community pharmacies, supporting a life-course approach to immunisation. 👥 Improve vaccination equity and uptake through national strategies targeting disadvantaged groups, promoting cross-sectoral collaboration, and best practices. Key actions to support these recommendations: 🔹 Adequately resourced National Immunisation Technical Advisory Groups (NITAGs) to evaluate vaccines efficiently and timely. 🔹 EU-level collaboration among NITAGs can help reduce capacity pressures and avoid duplication of efforts. 🔹 Fostering collaboration with sectors like education and employment can ensure more equitable access for all. By taking these steps, Europe can build a future where every citizen has equal access to vaccines, improving public health and reducing inequalities. Stay tuned for Chapter 4 where we’ll explore convergence and alignment of immunisation programmes! 👉 https://lnkd.in/ehVPf-px

Exploring Chapter 2 of our Consensus Report: Beliefs, perceptions, and vaccine confidence! Vaccination remains one of the greatest achievements in public health. Yet, across the EU, vaccine confidence faces growing challenges: ➡ Misinformation spreading through social media ➡ Shifting policies and government trust ➡ The introduction of new vaccines ➡ Disease outbreaks and pandemics These factors contribute to vaccine hesitancy, driving the resurgence of vaccine-preventable diseases (VPDs) and highlighting the need for urgent, coordinated action at local, national, and European levels. 📊 Key insight: The State of Vaccine Confidence in the EU report reveals a troubling trend—younger adults (18–34) are becoming less confident about vaccines compared to older generations. Our recommended actions: 🚨 Develop an EU vaccine confidence rapid alert and response system to enable timely risk analysis and policy action. 👥 Strengthen community engagement on vaccination through national strategies, research and exchange of best practice. 💬 Ensure training on vaccination and communication skills for pre- and in- service health care professionals. Building trust and fostering collaboration are essential to achieving high vaccination coverage and protecting communities across Europe. Stay tuned for Chapter 3: Citizens’ Access to Vaccines—coming soon! 👉 https://lnkd.in/ehVPf-px

Let’s dive into Chapter 1 of our Consensus Report: Data and evidence for decision-making! 📊 Data and evidence are the backbone of effective vaccination strategies – they inform and guide decision-making on new vaccines and vaccination programs, support the surveillance of vaccine-preventable diseases (VPDs), and monitor vaccination coverage and confidence. Yet, critical gaps remain that hinder progress, including: ➡ Lack of nationwide data on complications linked to several infections in population subgroups, as well as on vaccination coverage rates (VCRs). ➡ Fragmented national approaches to the evaluation of vaccines/vaccination programmes, leading to diverging levels of health protection across European countries. Our recommended actions: 🔍 Enhance data collection and evidence generation to support the strengthening of vaccination policies, strategies, and the broader health care system. 💡 Strengthen the alignment of national approaches to evidence-based decision-making on vaccination through a common European value framework: Let’s harness the power of data to drive impactful vaccination policies and strengthen programs across Europe! 🌍 Stay tuned for Chapter 2, where we explore our recommendations on vaccine beliefs, perceptions and confidence! Read more 👉 https://lnkd.in/ehVPf-px

🎉 The MBVE continues to expand its membership! We are excited to welcome ESNO, European Specialist Nurses Organisation as our newest MBVE member! ESNO brings together specialist nurses across Europe to promote the health and well-being of Europeans, including in supporting vaccination efforts. 🎯 ESNO's priorities closely align with MBVE, particularly in improving education and training of healthcare to address knowledge gaps, improve communication skills, combat misinformation, and boost public confidence in vaccination. We look forward to impactful collaboration with ESNO! 🤝

𝗔 𝗿𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝘄𝗲𝗲𝗸 𝗳𝗼𝗿 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗲𝗳𝗳𝗼𝗿𝘁𝘀! This week has been filled with important discussions on vaccination and life-course immunisation: 📅 15 October: Vaccines Europe and AIPM hosted the "Immunisation for Life Conference". 📅 16 October: The Steering Group on Influenza Vaccination hosted the EU Flu Day. Both events brought together high-level public health and immunisation experts, including MBVE members, policymakers, and patient advocates. We were also deeply moved by the powerful testimony of Anaïs, sharing a personal story of complications from influenza, encouraging immunisation. 𝗞𝗲𝘆 𝘁𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀: ✔️ 𝗧𝗵𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗼𝗳 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗮𝗿𝗲 𝗶𝗺𝗺𝗲𝗻𝘀𝗲: They not only represent a strong economic investment for society, but also reduce mortality, morbidity, complications, and antibiotic use, while promoting healthy ageing. ✔️ 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀 𝗿𝗲𝗺𝗮𝗶𝗻: Misinformation and vaccine hesitancy, particularly among younger populations, are driven by a lack of trust in institutions. 𝗪𝗵𝗮𝘁 𝗰𝗮𝗻 𝘄𝗲 𝗱𝗼?  💡 𝗟𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 to sustain life-course immunisation. 💡 𝗖𝗼𝗺𝗯𝗮𝘁 𝗺𝗶𝘀𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 with evidence-based awareness campaigns through effective communication on vaccines and healthcare professionals training. 💡 𝗘𝘅𝗽𝗮𝗻𝗱 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝗮𝗰𝗰𝗲𝘀𝘀 beyond traditional healthcare settings, including schools, workplaces, and pharmacies. 💡 𝗗𝗲𝘃𝗲𝗹𝗼𝗽 𝗮𝗻 𝗘𝗨 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗪𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 focused on improving healthcare practitioners’ education on immunisation and communication with patients. 💡 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗲 𝗱𝗮𝘁𝗮 𝗮𝗻𝗱 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘁𝗼𝗼𝗹𝘀 for continuous monitoring and data-driven immunisation strategies, drawing on existing good practices as examples. 💡 𝗪𝗼𝗿𝗸 𝘁𝗼𝘄𝗮𝗿𝗱𝘀 𝗯𝗲𝘁𝘁𝗲𝗿 𝘁𝗿𝗮𝗰𝗸𝗶𝗻𝗴 𝗼𝗳 𝗶𝗺𝗺𝘂𝗻𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗿𝗮𝘁𝗲𝘀 across EU Member States, with a unified IT system and an electronic vaccination passport for all Europeans. 💡 𝗟𝗲𝗮𝗿𝗻 𝗳𝗿𝗼𝗺 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀 𝘄𝗵𝗼 𝗮𝗰𝗵𝗶𝗲𝘃𝗲𝗱 𝘁𝗵𝗲 𝟳𝟱% 𝗳𝗹𝘂 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝘁𝗮𝗿𝗴𝗲𝘁 and expand it to include COVID-19 and RSV vaccinations. #EUFluDay #LifeCourse #Immunisation #Vaccination #PublicHealth

🌟 MBVE Meeting - 7 October 2024 🌍 This week, the Mission Board on Vaccination in Europe (MBVE) held an exciting members’ meeting, welcoming new members Gediminas Černiauskas, Hristiana Batselova and observing member EuroHealthNet. We took stock of our progress and discussed our plans for 2025 to drive forward immunisation efforts under the new European mandate 🇪🇺 Some key highlights: 👉 We’re initiating discussions around two flagship programmes aimed at turning our vision into action 👉 We engaged in fruitful discussions to ensure that immunisation policies remain a top priority in EU health policy. 🤝 We are also planning an exciting event early next year! Stay tuned, more information on this soon!  https://lnkd.in/g-pwcX42.

Have you read our first Consensus report? 📘 Dive into the MBVE Consensus report, which delivers concrete recommendations aimed at strengthening vaccination policies and programmes across Europe. 🔍 What’s inside?  👉 Our report is structured into four thematic chapters, each addressing a critical aspect of vaccination: 1️ Data and evidence for decision-making 2️ Beliefs, perceptions, and vaccine confidence 3️ Citizens’ access to vaccines 4️ Convergence and alignment across Europe 🔬 Each chapter was developed by a working group (WG), under the leadership of an expert in their respective field. 🤝 Alongside the chapters, the report highlights key cross-cutting themes that emphasise a holistic approach to immunisation: -              A life course approach to immunisation -              Intersectoral collaboration -              Strengthened and sustainable financing of immunisation systems -              Immunisation system performance monitoring and assessment 👉 Find the report on our website here https://lnkd.in/ehVPf-px 📢 Stay tuned as we dive deep into each chapter of the report & explore how these recommendations have the potential shape the future of immunisation!

Meet our MBVE experts! 🌎 The MBVE brings together public health experts, healthcare professionals, civil society, patient representatives, and industry from around Europe, united by the mission to enhance immunisation policies and systems. 🎓 Our Chair: Professor Walter Ricciardi, a renowned Public Health leader and Full Professor of Public Health at Catholic University of the Sacred Heart (Rome). With many years of experience, he has been President of the Italian National Institute of Health, scientific advisor to the Italian Minister of Health for the COVID-19 emergency and is the Chair of the European Commission Mission Board for Cancer. As our Chair, he guides our mission with unparalleled expertise in preventive policies and immunization strategies. 🔬 Our Members & Areas of Expertise: We are proud to collaborate with experts from 13 European countries and 9 associations, each bringing unique expertise and in-depth knowledge to advance our collective mission. They specialise in a wide range of areas, including: -Vaccinology and life course immunisation -Infectious diseases -Tropical medicine -Paediatrics -Medicine and Surgery -Cancer Their combined knowledge allows us to address the most pressing challenges in vaccination, setting ambitious targets to strengthen immunisation policies and programmes across Europe. We also have the honor to welcome EuroHealthNet, the partnership of public health bodies, as our first Observing Member! 📘 Want to dive deeper? 👉 Check our work at https://lnkd.in/ehVPf-px